White label ELPA - ClinicalTrials.eu

Study on the Safety and Effectiveness of Garetosmab for Adults with Fibrodysplasia Ossificans Progressiva

Not recruiting

3 1
Investigated diseases:
- Fibrodysplasia ossificans progressiva
Investigated drugs:
- Garetosmab
Study on the Effects of Amikacin Liposome Inhalation, Azithromycin, and Ethambutol in Adults with Newly Diagnosed Nontuberculous Mycobacterial Lung Infection

Not recruiting

3 1 1
Investigated diseases:
- Pneumonia
Investigated drugs:
+5
Study on TAR-200 and Cetrelimab for High-Risk Bladder Cancer Patients Not Responding to BCG and Unable or Unwilling to Have Surgery

Not recruiting

2 1 1
Investigated diseases:
- Bladder transitional cell carcinoma
Investigated drugs:
- Cetrelimab
- Gemcitabine Hydrochloride
+2
Study on the Effectiveness and Safety of Oral Midazolam for Elderly Patients with Severe Neurocognitive Disorders and Care Resistance

Not recruiting

2 1 1 1
Investigated diseases:
- Cognitive disorder
Investigated drugs:
- Midazolam
Study on the Safety and Effects of Mosunetuzumab and Lenalidomide for Patients with Follicular Lymphoma

Not recruiting

1 1 1 1
Investigated diseases:
- Follicular lymphoma
Investigated drugs:
Study Comparing Subcutaneous and Intravenous Isatuximab with Pomalidomide and Dexamethasone for Adults with Relapsed or Refractory Multiple Myeloma

Not recruiting

3 1 1 1
Investigated diseases:
- Plasma cell myeloma recurrent
Investigated drugs:
+4
Study on the Long-Term Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa

Not recruiting

3 1 1
Investigated diseases:
- Hidradenitis
Investigated drugs:
- 4-[3-(Cyanomethyl)-3-(3′,5′-Dimethyl-1H,1’H-[4,4′-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide
+6
Study on the Safety and Effectiveness of Epcoritamab, Venetoclax, and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Richter’s Syndrome

Not recruiting

1 1 1 1
Investigated diseases:
- Chronic lymphocytic leukaemia
Investigated drugs:
+3
Study on Dronabinol for Reducing Severe Breathlessness in Patients with Severe and Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Not recruiting

4 1 1
Investigated diseases:
- Chronic obstructive pulmonary disease
Investigated drugs:
- Dronabinol
- Placebo
Study on Rivaroxaban, Dabigatran Etexilate, and Fluindione for Patients with Intra-Cardiac Thrombus

Not recruiting

3 1 1 1
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies